DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation

NCT00083915 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Cisplatin
DRUG: Cyclophosphamide
DRUG: Adriamycin
DRUG: Etoposide
DRUG: Melphalan
DRUG: Thalidomide
DRUG: Dexamethasone

Sponsor

University of Arkansas